{"nct_id":"NCT02238925","title":"An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients","status":"COMPLETED","status_verified_date":"2017-10","start_date":"2014-07","start_date_type":null,"primary_completion_date":"2015-05","primary_completion_date_type":"ACTUAL","completion_date":"2016-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JAZZ"]}